Chi-Long Chen Selected Research

Epstein-Barr virus EBV-associated membrane antigen

1/2013	Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
8/2009	Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
6/2002	Expression of Epstein-Barr virus latent membrane protein 1 and B-cell leukemia-lymphoma 2 gene in nasopharyngeal carcinoma tissues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chi-Long Chen Research Topics

Disease

42	Neoplasms (Cancer) 03/2022 - 01/2002
13	Neoplasm Metastasis (Metastasis) 03/2022 - 03/2008
13	Nasopharyngeal Carcinoma 09/2015 - 01/2002
9	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 01/2013
8	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2009
5	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 01/2013
5	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 11/2012
5	Squamous Cell Carcinoma of Head and Neck 01/2017 - 01/2014
4	Lymphoma (Lymphomas) 08/2005 - 06/2002
3	Lymphatic Metastasis 03/2022 - 03/2008
3	Colonic Neoplasms (Colon Cancer) 07/2021 - 01/2017
3	Lung Neoplasms (Lung Cancer) 01/2020 - 07/2015
3	Carcinogenesis 09/2019 - 08/2009
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017 - 01/2005
3	Prostatic Neoplasms (Prostate Cancer) 07/2016 - 01/2014
3	Inflammation (Inflammations) 01/2016 - 01/2012
3	Infections 09/2015 - 02/2005
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2020 - 03/2008
2	Triple Negative Breast Neoplasms 01/2020 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 07/2015 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2015 - 03/2008
2	Pneumonia (Pneumonitis) 04/2012 - 04/2008
2	Disease Progression 03/2008 - 09/2005
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 09/2005 - 08/2005
1	Mouth Neoplasms (Oral Cancer) 03/2022
1	Hyperthermia 10/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 08/2019 - 09/2003
9	Biomarkers (Surrogate Marker)IBA 07/2021 - 11/2012
7	Messenger RNA (mRNA)IBA 01/2020 - 07/2003
4	RNA (Ribonucleic Acid)IBA 01/2017 - 04/2008
3	CateninsIBA 12/2020 - 03/2016
3	ParaffinIBA 10/2019 - 09/2004
3	EnzymesIBA 09/2019 - 05/2016
3	Pharmaceutical PreparationsIBA 01/2019 - 03/2006
3	Biological ProductsIBA 12/2016 - 04/2009
3	Epstein-Barr virus EBV-associated membrane antigenIBA 01/2013 - 06/2002
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2010 - 02/2005
2	TOR Serine-Threonine KinasesIBA 01/2020 - 06/2014
2	Estrogen ReceptorsIBA 01/2020 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 06/2014
2	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2020 - 08/2019
2	Coloring Agents (Dyes)IBA 08/2019 - 03/2008
2	IntegrinsIBA 01/2019 - 01/2019
2	tetraiodothyroacetic acid (TA(4))IBA 01/2019 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 07/2003
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2014
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2017 - 07/2010
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 12/2016
2	Conditioned Culture MediaIBA 01/2017 - 01/2016
2	TeaIBA 04/2016 - 01/2015
2	LipopolysaccharidesIBA 01/2016 - 04/2012
2	Phosphotransferases (Kinase)IBA 01/2016 - 06/2014
2	Cadherins (E-Cadherin)IBA 07/2015 - 01/2015
2	CaspasesIBA 09/2013 - 01/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2013 - 03/2006
2	Keratins (Keratin)IBA 12/2011 - 12/2006
2	NF-kappa B (NF-kB)IBA 08/2005 - 09/2004
1	fas Receptor (CD95 Antigen)IBA 03/2022
1	CollagenIBA 10/2021
1	Collagen Type V (Type V Collagen)IBA 10/2021
1	PlatinumIBA 10/2021
1	IonsIBA 10/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 10/2021
1	Bentonite (Montmorillonite)IBA 10/2021
1	IronIBA 10/2021
1	Contrast MediaIBA 10/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Interleukin-2 Receptor alpha SubunitIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Apoptosis Regulatory ProteinsIBA 12/2020
1	Chaperonin Containing TCP-1IBA 12/2020
1	SurvivinIBA 12/2020
1	Monoamine Oxidase (MAO)IBA 04/2020
1	olaparibIBA 02/2020
1	TNF Receptor-Associated Factor 4IBA 01/2020
1	Phospholipases (Phospholipase)IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	AnthracyclinesIBA 01/2020
1	Codon (Codons)IBA 10/2019
1	Formaldehyde (Formol)FDA Link 10/2019
1	XenobioticsIBA 09/2019
1	Aldo-Keto Reductase Family 1 member B10IBA 09/2019
1	Adenosine Triphosphate (ATP)IBA 07/2019
1	Globo-HIBA 01/2019
1	Membrane LipidsIBA 01/2019
1	Caveolin 1IBA 01/2019
1	GlycosphingolipidsIBA 01/2019
1	AntibodiesIBA 01/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019

Therapy/Procedure

13	Therapeutics 10/2021 - 09/2005
7	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
3	Lasers (Laser) 01/2017 - 10/2006
1	Intravenous Injections 03/2022
1	Precision Medicine 10/2021